Author
NYU Langone HealthORCID 0009-0003-4966-5281Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Katherine Parker, Samar Ghorbanpoor, Wafa Malik…·Aaron N. Hata
This study shows that a dual inhibitor of KRASG12C in both ON and OFF states more effectively suppresses tumor growth than an OFF-specific inhibitor by reducing PI3K-AKT activation.
Wen-Hsuan Chang, Alec J. Vaughan, Addison G. Stamey…·Channing J. Der
This study identifies KEAP1 loss as a resistance mechanism to KRAS inhibitors in pancreatic and lung cancer and shows that combining glutamine inhibition with KRAS inhibitors can overcome this resistance.
Angeliki Karatza, Maayan Pour, Jaylen M Powell…·Kwok‐Kin Wong
This study identifies genotype-specific immune and metabolic vulnerabilities in lung adenocarcinoma through cross-species analysis of human and mouse tumors.